Dai-ichi Life Insurance Company, Ltd - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,045 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Dai-ichi Life Insurance Company, Ltd ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2023$200,510
-10.6%
4,4010.0%0.00%
-20.0%
Q4 2022$224,319
-83.8%
4,401
-82.9%
0.01%
-85.3%
Q3 2022$1,388,000
-47.0%
25,775
-36.8%
0.03%
-41.4%
Q2 2022$2,619,000
-17.2%
40,7750.0%0.06%
+16.0%
Q1 2022$3,162,000
-9.7%
40,7750.0%0.05%
+11.1%
Q4 2021$3,500,000
+6.7%
40,7750.0%0.04%
+4.7%
Q3 2021$3,280,000
-3.4%
40,775
-3.3%
0.04%
+2.4%
Q2 2021$3,395,000
-4.6%
42,1720.0%0.04%
-14.3%
Q1 2021$3,557,000
+5.1%
42,1720.0%0.05%0.0%
Q4 2020$3,384,000
-0.2%
42,1720.0%0.05%
-19.7%
Q3 2020$3,391,000
-6.6%
42,1720.0%0.06%
-26.5%
Q2 2020$3,631,000
+5.0%
42,172
-1.0%
0.08%
-37.6%
Q1 2020$3,457,000
-2.9%
42,5830.0%0.13%
+64.2%
Q4 2019$3,561,000
-5.1%
42,583
-0.7%
0.08%
-10.0%
Q3 2019$3,751,000
+6.8%
42,8870.0%0.09%
+5.9%
Q2 2019$3,512,000
+0.7%
42,8870.0%0.08%
-1.2%
Q1 2019$3,487,000
-81.4%
42,887
-84.9%
0.09%
-83.1%
Q4 2018$18,714,000
-14.6%
284,3160.0%0.51%
+7.4%
Q3 2018$21,918,000
+143.5%
284,316
+133.3%
0.48%
+118.9%
Q2 2018$9,000,000
-0.4%
121,887
-12.3%
0.22%
+16.0%
Q1 2018$9,040,000
+0.6%
138,9880.0%0.19%
+7.5%
Q4 2017$8,984,000
+3.0%
138,9880.0%0.17%
-5.9%
Q3 2017$8,721,000
-6.4%
138,988
-9.7%
0.18%
-10.6%
Q2 2017$9,322,000
+12.6%
153,988
-3.5%
0.21%
-7.6%
Q1 2017$8,278,000
+213.2%
159,615
+167.7%
0.22%
+187.2%
Q4 2016$2,643,00059,6150.08%
Other shareholders
BAXTER INTL INC shareholders Q4 2017
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders